最新报道:According to Bijie.com, Nasdaq-listed Qualigen Therapeutics (QLGN) announced that it has completed the construction of infrastructure, including US dollar cash settlement, bank accounts, and cryptocurrency custody accounts, over the past two weeks. It will officially begin purchasing its first strategic assets this week, primarily investing in the top 10 cryptocurrencies by market capitalization, with a focus on blue-chip crypto assets such as BNB, ETH, and SOL. Previously, FF had made a strategic investment of $41 million in Nasdaq-listed QLGN, with Jia Yueting investing $4 million. QLGN will be renamed CXC 10. (globenewswire)